Literature DB >> 20390459

Managing elderly soft tissue sarcoma patients-should age drive treatment?

Dina Lev, Raphael E Pollock.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20390459     DOI： 10.1245/s10434-010-1035-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  The prognostic significance of surgical treatment for excessive elderly patients with soft tissue sarcoma.

Authors:  Hiroyuki Tsuchie; Makoto Emori; Hiroyuki Nagasawa; Naohisa Miyakoshi; Yasutaka Murahashi; Emi Mizushima; Toshihiko Yamashita; Yoichi Shimada
Journal:  Int J Clin Oncol       Date:  2018-02-27       Impact factor: 3.402

2.  Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.

Authors:  A L Cesne; I Judson; R Maki; F Grosso; S Schuetze; M V Mehren; S P Chawla; G D Demetri; A Nieto; A Tanovic; J-Y Blay
Journal:  Br J Cancer       Date:  2013-09-10       Impact factor: 7.640

3.  Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses.

Authors:  Axel Le Cesne; Sebastian Bauer; George D Demetri; Guangyang Han; Luca Dezzani; Qasim Ahmad; Jean-Yves Blay; Ian Judson; Patrick Schöffski; Massimo Aglietta; Peter Hohenberger; Hans Gelderblom
Journal:  BMC Cancer       Date:  2019-08-13       Impact factor: 4.430

Review 4.  Benefits of Minimal Access Surgery in Elderly Patients with Pelvic Cancer.

Authors:  Vincent Lavoué; Walter Gotlieb
Journal:  Cancers (Basel)       Date:  2016-01-12       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.